Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Inicio Explorar nav.journalClub Tendencias

⌘+K

Africa may lead rollout of long-lasting HIV drug | Synapse

March 28, 2024Science2 citationsOpen Access

Africa may lead rollout of long-lasting HIV drug

Ver artículo completo

JCJon CohenSylvester Comprehensive Cancer Center

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

U.S. agency plans to make inexpensive prevention shots widely available for people at risk.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Jon Cohen (2024) studied this question.

synapsesocial.com/papers/68e720ceb6db64358769a20a https://doi.org/https://doi.org/10.1126/science.adp4711

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Landmark trial may herald new era in HIV prevention2024 · 3 citations
2Africa is an Essential Partner in the Research and Development of an HIV Vaccine2025 · 2 citations
3Lenacapavir and global HIV prevention: a breakthrough at risk of leaving millions behind2026 · 5 citations
4A rocky rollout2026
5The Lenacapavir Paradox: why a promising HIV prevention tool may undermine progress toward ending AIDS in Africa2025